The positive movement in INSP's stock price is directly attributed to JP Morgan's defense of the stock. This kind of support from a major financial institution typically instills confidence in investors, especially when it comes in response to potentially concerning data from another company in a related field. The backing by JP Morgan suggests a strong belief in Inspire Medical Systems' fundamentals or market position, despite any implications Lilly's sleep apnea data might have had on the market's perception of sleep apnea treatments and related stocks.